Cell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.
Jason Birri
Advertisement
Articles by Jason Birri
Advertisement
Latest Updated Articles
A Roadmap to Phase I Challenges for Cell and Gene Therapy ProductsPublished: October 10th 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Genentech’s Phase III MEERKAT and SANDCAT Trials Show Vision and Anatomical Gains With Vamikibart in Uveitic Macular Edema
2
Honing the Power of AI for Next Generation Trial Oversight and Execution
3
ACT Brief: AI-Driven Oversight, Biotech Acceleration Strategies, and a Major Win in Bladder Cancer
4
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
